NEW YORK (GenomeWeb News) — Sensigen has acquired an option from the University of Michigan to exclusively license a set of epigenetic biomarkers that can detect and monitor lupus, the company said this week.
 
The technology covered under the license is a panel of biomarkers of epigenetic variations of genes and related research assays linked to lupus, the company said.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.